Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-139527
Filing Date
2024-12-23
Accepted
2024-12-23 15:30:52
Documents
1
Period of Report
2024-12-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 10864
  Complete submission text file 0000950170-24-139527.txt   12235
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Issuer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address 28 REICHERT CIRCLE WESTPORT CT 06880
Business Address
GULATI CHETAN (Reporting) CIK: 0001838456 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-56075 | Film No.: 241573240